Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of Everolimus Transition in Minimizing Progressive Graft Dysfunction and Interstitial Fibrosis in Adult Kidney Transplant Recipients

NCT02096107 is registered in ClinicalTrials.gov with Medical University of South Carolina as lead sponsor.

NCT NCT02096107
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02096107 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of Everolimus Transition in Minimizing Progressive Graft Dysfunction and Interstitial Fibrosis in Adult Kidney Transplant Recipients
Lead sponsor
Medical University of South Carolina
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2014
Completion date
May 31, 2017
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

graft dysfunction, interstitial fibrosis